VIA DERMIS XL Trademark

Trademark Overview

On Thursday, January 18, 2024, a trademark application was filed for VIA DERMIS XL with the United States Patent and Trademark Office. The USPTO has given the VIA DERMIS XL trademark a serial number of 98363834. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 15, 2024. This trademark is owned by Vivex Biologics Group, Inc.. The VIA DERMIS XL trademark is filed in the Pharmaceutical Products category with the following description:

Biological dermal tissue intended for subsequent implantation
via dermis xl

General Information

Serial Number98363834
Word MarkVIA DERMIS XL
Filing DateThursday, January 18, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2024

Trademark Statements

Goods and ServicesBiological dermal tissue intended for subsequent implantation
NOT AVAILABLE"DERMIS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 18, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVivex Biologics Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339
Party NameVivex Biologics Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339

Trademark Events

Event DateEvent Description
Thursday, January 18, 2024NEW APPLICATION ENTERED
Wednesday, July 10, 2024ASSIGNED TO EXAMINER
Monday, July 15, 2024EXAMINERS AMENDMENT E-MAILED
Monday, July 15, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, July 15, 2024EXAMINER'S AMENDMENT ENTERED
Monday, July 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 15, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 20, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 20, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

dermis subsequent implantation intended tissue dermal biological